Literature DB >> 30806956

α7nAChR Deletion Aggravates Myocardial Infarction and Enhances Systemic Inflammatory Reaction via mTOR-Signaling-Related Autophagy.

Jinyan Fang1, Jiawei Wang2, Fanghui Chen1, Yuansheng Xu1, Hao Zhang1, Yi Wang3.   

Abstract

Alpha7 nicotinic acetylcholine receptor (α7nAChR) has been previously reported to play an alleviative role in myocardial infarction (MI). In this study, we investigated its specific mechanism. α7nAChR-/- mice and its control (α7nAChR+/+) were used for the study of α7nAChR. Left anterior descending coronary artery occlusion was conducted for the creation of mice MI model and lipopolysaccharide (LPS) was used as inflammatory stressor in murine peritoneal macrophages. Triphenyltetrazolium chloride (TTC) staining and echocardiography was used for the detection of infarct size and cardiac function, respectively. Western blot was conducted for the testing of autophagy-related proteins and enzyme-linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (RT-PCR) was used for the testing of proinflammatory cytokines. Rapamycin was used for the induction of autophagy through inhibiting mammalian target of rapamycin (mTOR)-related signaling. We found that knocking out α7nAChR enhanced the cardiac infarct size and damaged cardiac function in MI. α7nAChR deficiency increased the levels of several proinflammatory cytokines in serum and spleen from MI mice as well as murine macrophages under inflammatory stress. α7nAChR deletion decreased the level of autophagy in spleen from MI mice and macrophages under inflammatory stress. Rapamycin alleviated the cardiac function and systemic inflammatory reaction in MI mice as well as inflammatory reaction in macrophages under inflammatory stress, which was attenuated by knocking out α7nAChR. Our current study investigated the mechanism of α7nAChR-mediated cardio-protective and anti-inflammatory effect related to mTOR-related autophagy, which might provide a novel insight in the treatment of MI.

Entities:  

Keywords:  alpha7 nicotinic acetylcholine receptor; autophagy; lipopolysaccharide; mammalian target of rapamycin; myocardial infarction

Mesh:

Substances:

Year:  2019        PMID: 30806956     DOI: 10.1007/s10753-019-00979-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  4 in total

1.  Alpha7 Nicotinic Acetylcholine Receptor Alleviates Inflammatory Bowel Disease Through Induction of AMPK-mTOR-p70S6K-Mediated Autophagy.

Authors:  Bo-Zong Shao; Shu-Ling Wang; Jun Fang; Zhao-Shen Li; Yu Bai; Kai Wu
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

2.  A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.

Authors:  Hong Xing; Sunil Keshwah; Anne Rouchaud; William R Kem
Journal:  Mar Drugs       Date:  2020-02-11       Impact factor: 5.118

Review 3.  Manipulation of the inflammatory reflex as a therapeutic strategy.

Authors:  Mark J Kelly; Caitríona Breathnach; Kevin J Tracey; Seamas C Donnelly
Journal:  Cell Rep Med       Date:  2022-07-19

Review 4.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.